News | April 07, 2022
Indian pharma growth likely to moderate in FY23: ICRA
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
GE Healthcare and Elekta aim to meet the major need for radiotherapy solutions across both developed and developing markets
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
Fujifilm has been at the forefront of medical imaging and healthcare informatics. It’s developing new AI platforms to address medical challenges. Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India gives us an insight in an interview with Thomas C. Thottathil, Editor, indianpharmapost.com
The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".
New collaboration will help customers reach sustainability goals for high-performance Udel PSU polymers in demanding applications.
The fund will take equity positions in India-focused healthcare and life sciences-related companies
The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies
The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
Subscribe To Our Newsletter & Stay Updated
